We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHIL
3101
DELISTED
Benson Hill, Inc.
BHIL
$42K ﹤0.01%
+168
New +$58.1K
GOL
3102
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$42K ﹤0.01%
5,476
+1,119
+26% +$8.71K
RETA
3103
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$42K ﹤0.01%
419
-892
-68% -$105K
EXTN
3104
DELISTED
Exterran Corporation
EXTN
$42K ﹤0.01%
9,503
+9,494
+105,489% +$40.3K
SRGA
3105
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$42K ﹤0.01%
1,281
-324
-20% -$11.9K
STXB
3106
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$42K ﹤0.01%
1,701
-2,374
-58% -$54.6K
RBNC
3107
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$42K ﹤0.01%
1,347
-1,950
-59% -$55.5K
ACIC icon
3108
American Coastal Insurance
ACIC
$461M
$41K ﹤0.01%
11,471
+8,032
+234% +$32.3K
BLFS icon
3109
BioLife Solutions
BLFS
$1.72B
$41K ﹤0.01%
966
+371
+62% +$17.9K
CUE icon
3110
Cue Biopharma
CUE
$131M
$41K ﹤0.01%
93
-78
-46% -$27.2K
CVGW
3111
DELISTED
Calavo Growers
CVGW
$41K ﹤0.01%
1,067
+170
+19% +$8.49K
DLX icon
3112
Deluxe
DLX
$1.11B
$41K ﹤0.01%
1,133
-798
-41% -$32.4K
DMLP icon
3113
Dorchester Minerals
DMLP
$1.35B
$41K ﹤0.01%
+2,130
New +$35.8K
GLDM icon
3114
SPDR Gold MiniShares Trust
GLDM
$29.8B
$41K ﹤0.01%
1,172
+1,132
+2,830% +$40.3K
IMAX icon
3115
IMAX
IMAX
$2.92B
$41K ﹤0.01%
2,176
-2,976
-58% -$49.4K
LDI icon
3116
loanDepot
LDI
$320M
$41K ﹤0.01%
6,104
+4,701
+335% +$43.9K
NVRI icon
3117
Enviri
NVRI
$564M
$41K ﹤0.01%
2,436
-17,190
-88% -$318K
RYTM icon
3118
Rhythm Pharmaceuticals
RYTM
$7.99B
$41K ﹤0.01%
3,197
-538
-14% -$8.22K
VSTM icon
3119
Verastem
VSTM
$604M
$41K ﹤0.01%
1,102
-280
-20% -$10.3K
JNCE
3120
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$41K ﹤0.01%
5,502
-4,711
-46% -$29.2K
SJR
3121
DELISTED
Shaw Communications Inc.
SJR
$41K ﹤0.01%
1,417
-4,710
-77% -$136K
AHT
3122
Ashford Hospitality Trust
AHT
$20.2M
$40K ﹤0.01%
271
+100
+58% +$16.9K
AKRO
3123
DELISTED
Akero Therapeutics
AKRO
$40K ﹤0.01%
1,791
-961
-35% -$21.8K
AUTL
3124
Autolus Therapeutics
AUTL
$591M
$40K ﹤0.01%
6,048
+3,462
+134% +$21.9K
BFAM icon
3125
Bright Horizons
BFAM
$3.85B
$40K ﹤0.01%
287
-267
-48% -$39.2K
123 124
125
126 127

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.